Variability of ferritin measurements in chronic kidney disease; implications for iron management
被引:47
|
作者:
Ford, Bradley A.
论文数: 0引用数: 0
h-index: 0
机构:
Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USAWashington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA
Ford, Bradley A.
[1
]
Coyne, Daniel W.
论文数: 0引用数: 0
h-index: 0
机构:
Washington Univ, Dept Med, St Louis, MO 63110 USAWashington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA
Coyne, Daniel W.
[2
]
Eby, Charles S.
论文数: 0引用数: 0
h-index: 0
机构:
Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA
Washington Univ, Dept Med, St Louis, MO 63110 USAWashington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA
Eby, Charles S.
[1
,2
]
Scott, Mitchell G.
论文数: 0引用数: 0
h-index: 0
机构:
Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USAWashington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA
Scott, Mitchell G.
[1
]
机构:
[1] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA
[2] Washington Univ, Dept Med, St Louis, MO 63110 USA
Serum ferritin levels are a proxy measure of iron stores; existing guidelines for managing anemia in hemodialysis patients suggest that serum ferritin concentrations should be maintained at > 200 ng/ml. The KDOQI recommendations further state there is insufficient evidence advocating routine intravenous iron when ferritin levels exceed 500 ng/ml. Here we determined the interassay differences and short-term intraindividual variability of serum ferritin measurements in patients on chronic hemodialysis to illustrate how these variances may affect treatment decisions. Intermethod variations of up to 150 ng/ml were found comparing six commonly used ferritin assays that evaluated thirteen pools of serum from hemodialysis and nonhemodialysis patients. The intraindividual variability for ferritin in 60 stable hemodialysis patients ranged between 2-62% measured over an initial two-week period and from 3-52% when factored over a six-week period. Our results suggests that single serum ferritin values should not be used to guide clinical decisions regarding treatment of chronic hemodialysis patients with intravenous iron due to significant analytical and intraindividual variability.
机构:
Hofstra North Shore LIJ Sch Med, Dept Med, Div Nephrol, Great Neck, NY USAHofstra North Shore LIJ Sch Med, Dept Med, Div Nephrol, Great Neck, NY USA
机构:
Univ Calif San Francisco, Dept Med, VA Cent Calif Hlth Care Syst, 2615 E Clinton Ave, San Francisco, CA 93703 USAUniv Calif San Francisco, Dept Med, VA Cent Calif Hlth Care Syst, 2615 E Clinton Ave, San Francisco, CA 93703 USA
机构:
St George Hosp, Dept Haematol, Ctr Haemostasis & Thrombosis, Blackshaw Rd, London SW17 0QT, EnglandSt George Hosp, Dept Haematol, Ctr Haemostasis & Thrombosis, Blackshaw Rd, London SW17 0QT, England
Peng, Ying Y.
Uprichard, James
论文数: 0引用数: 0
h-index: 0
机构:
St George Hosp, Dept Haematol, Ctr Haemostasis & Thrombosis, Blackshaw Rd, London SW17 0QT, EnglandSt George Hosp, Dept Haematol, Ctr Haemostasis & Thrombosis, Blackshaw Rd, London SW17 0QT, England